For the second trading session in less than a week, Roche Holding ( RHHBY -6.02%) stock really took it on the chin Wednesday.

Roche's diversified portfolio and ongoing GLP-1 developments offer decent upside with limited downside. Read more about RHHBY ...

Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...

Novartis reportedly plans to cut 680 development jobs worldwide, separate from an 8,000-employee restructuring, aiming to reshape its workforce and tap local talent pools. Poseida Therapeutics Inc ...

BofA securities has upgraded Roche to a "buy," setting a target price of CHF 340, due to a positive outlook on the company's growth. Meanwhile, Deutsche Bank has downgraded the stock to "sell ...

Short interest in Roche Holding AG (OTC:RHHBY) decreased during the last reporting period, falling from 5.81M to 2.92M. This put -% of the company's publicly available shares short. Short interest ...

Vanguard International Stock Index-Vanguard European Stock Index 59.75k Apr 30, 2024 0.06% 19,840,617 Vanguard Intl Equity Index - Total World Stock Index Fd 68.53k Apr 30, 2024 0.06% 22,755,064 ...

FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an ...

It had a large slug of assets in developed Europe, including longtime holdings Nestle, Air Liquide, Schneider, and Roche. Stock selection rather than sector bets drive sector and region ...